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Genetic and biological variation in the regulatory protein Rev of equine infectious anemia virus (EIAV) were examined
throughout a clinically dynamic disease course of an experimentally infected pony. Following infection with the virulent
EIAVWyo, the pony underwent a variable disease course, including an acute fever episode at 12 days postinfection (DPI),
multiple recurrent fever episodes until 135 DPI, a prolonged subclinical period, and two late fever episodes. Viral RNA was
isolated from the inoculum and sequential sera samples, and the rev exon 2/gp45 overlapping ORFs were amplified, cloned,
and sequenced. Novel variants were found throughout infection, and genetic analyses indicated that both the Rev and gp45
ORFs were under selective pressure. The Rev variant predominant in the inoculum, R1, remained predominant during the
early periods following infection (until 35 DPI); however, R1 was replaced by new predominant variants during the recurrent
fever period (67–135 DPI). R1 reemerged as the predominant variant during the afebrile period, but a new predominant
variant, R93, was associated with the late fever episodes. Rev variants predominant during recurrent febrile and late-febrile
periods had significantly higher Rev-mediated nuclear export activity than the variants predominant during the acute and
afebrile periods. Statistical correlation was found between Rev activity and different stages of clinical disease. Together,
these results suggest that genetic and biological variation in rev may be a contributing factor in EIAV disease progression.
© 2001 Academic Press
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iINTRODUCTION
Equine infectious anemia virus (EIAV) possesses com-
mon features of the Lentiviridae subfamily of retrovi-
uses, including a complex genome organization, tro-
ism for cells of the monocyte/macrophage lineage, and
stablishment of a persistent, life-long infection. Many
entivirus infections are characterized by a slow, chronic
isease, but infection of horses with EIAV can result in an
cute, dynamic disease course characterized by recur-
ing cycles of viremia, fever, and thrombocytopenia, with
possible development of anemia (reviewed in Issel and
oggins, 1979). Fever cycles are typically irregular and
ay recur for up to 1 year, despite the onset of a neu-
ralizing-antibody response. Horses which survive these
nitial clinical episodes become life-long, inapparent car-
iers of the virus. The variable nature of clinical disease
nd the fact that most infected horses are able to control
irus replication and remain life-long inapparent carriers
ake EIAV infection an excellent model for studies of
1 These authors contributed equally to this work.
2 To whom correspondence and reprint requests should be ad-
ressed at Iowa State University, Department of VMPM, Room 1136 Vet
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185virus and host factors which contribute to lentivirus per-
sistence and pathogenesis.
Virus persistence over a life-long infection is depen-
dent on both host and viral factors. Genetic variation, the
result of errors produced by reverse transcriptase, is a
well-studied mechanism of lentivirus persistence (Hub-
ner et al., 1992; Ji and Loeb, 1994; Nowak, 1990; Patel and
Preston, 1994). The result of the genetic variation is the
accumulation of nonidentical, yet related, variants com-
monly referred to as a quasispecies (Domingo et al.,
996; Eigen, 1993; Holland et al., 1992). Selection acts on
he quasispecies population, and the diversity within the
opulation allows the virus to adapt to changes in se-
ective pressures. The quasispecies nature of EIAV is
argely the result of three regions of hypervariability: the
iral long terminal repeat (LTR), the surface envelope
SU), and a region where the major exon of Rev is
ompletely overlapped by the transmembrane protein
TM). Variation in SU, resulting from mutations, inser-
ions, or duplications within the principal neutralization
omain or hypervariable region, can alter antigenicity
nd facilitate evasion of host immune surveillance
Payne et al., 1984, 1987, 1989; Kono, 1969, 1972; Salinov-
ch et al., 1986; Perryman et al., 1988; Montelaro et al.,
990; Issel et al., 1990; Kono et al., 1973; Zheng et al.,
997). Studies examining the immune response of EIAV-
0042-6822/01 $35.00
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.
1R
c
v
p
d
f
H
1
a
m
a
T
v
5
b
o
a
t
T
5
s
f
m
D
r
b
w
c
r
e
n
l
r
p
186 BELSHAN ET AL.infected horses indicate that both cellular and humoral
immune responses contribute to suppression of virus
replication during inapparent stages of infection (Sali-
novich et al., 1986; Hammond et al., 1997). No subset of
the immune response, however, was ever previously
shown to specifically correlate with control of virus rep-
lication during long-term persistence (Hammond et al.,
1997).
Lentiviruses have evolved complex mechanisms to
regulate viral gene expression at the transcriptional and
posttranscriptional levels. Variation in regulatory ele-
ments such as the LTR and Rev may alter the level of
virus gene expression and, subsequently, viral replica-
tion (Carpenter et al., 1991; Alexandersen and Carpenter,
991; Maury et al., 1997). We and others described ge-
netic variation in the second exon of the EIAV regulatory
protein Rev (Alexandersen and Carpenter, 1991; Belshan
et al., 1998; Leroux et al., 1997), but the biological signif-
icance of Rev variation in vivo has not yet been explored.
ev functions to facilitate the nuclear export of the in-
ompletely spliced viral RNAs during the late phase of
irus replication. These viral RNAs encode the structural
roteins and serve as progeny RNA molecules. Rev-
ependent RNA export pathways have been described
or numerous lentiviruses (reviewed in Cullen, 1992;
ope, 1997), and the human immunodeficiency virus type
(HIV-1) Rev-mediated export pathway is the best char-
cterized. HIV-1 Rev binds a structure in the viral pre-
RNA, called the Rev-responsive element (RRE) (Zapp
nd Green, 1989), multimerizes (Olsen et al., 1990), then
utilizes the CRM1 nuclear export pathway to redirect
movement of incompletely spliced viral RNA from the
nucleus (Fornerod et al., 1997; Stade et al., 1997; Bogerd
et al., 1995; Stutz et al., 1995). Discrete functional do-
mains within Rev that mediate its interaction with cellular
proteins and viral RNA are required for nuclear localiza-
tion, RNA binding, multimerization, and nuclear export.
EIAV Rev is a 165 amino acid protein functionally homol-
ogous to HIV-1 Rev (Fridell et al., 1993). The major exon
encodes for the nuclear export signal of EIAV Rev, amino
acids 2–25 (Fridell et al., 1993) and was previously shown
to be able to substitute for the HIV-1 or visna virus
effector domains (Fridell et al., 1993; Mancuso et al.,
1994). A putative nuclear localization signal was previ-
ously mapped to the arginine-rich C-terminus of EIAV Rev
(Harris et al., 1998).
Rev is absolutely required for expression of viral struc-
tural genes and production of new virus. Therefore, fac-
tors which modulate Rev activity and, consequently, alter
levels of viral gene expression may be important in
regulating virus replication in vivo. Rev-attenuated phe-
notypes were previously identified during asymptomatic
stages of HIV-1 infection, suggesting that variation in Rev
could alter virus replication levels in vivo and contribute
to the clinical outcome of infection (Iversen et al., 1995;
Hua et al., 1996). We previously identified extensive nu-
d
lcleotide substitutions in the second exon of EIAV rev in
virus obtained from an experimentally infected horse
(Alexandersen and Carpenter, 1991). The coexistence of
putative Rev-competent and Rev-deficient phenotypes
suggested that variation in Rev may contribute to virus
persistence through regulation of virus replication. Sub-
sequent in vitro analysis indicated that limited amino
acid variation in Rev could alter Rev-mediated nuclear
export activity (Belshan et al., 1998), further suggesting
that variation in Rev may modulate virus replication dur-
ing disease.
In the present study, we undertook extensive genetic
and biological analyses of Rev quasispecies during long-
term persistence in a single experimentally infected
pony. Consistent with previous studies (Leroux et al.,
1997), novel rev variants were detected throughout infec-
tion. Significantly, changes in the genotype and pheno-
type of Rev quasispecies correlated with changes in
clinical stages of EIAV infection. These findings indicate
that genetic and biological changes in Rev contributed to
the selection of EIAV variants in vivo, and may be impor-
tant factors in lentivirus persistence and pathogenesis.
RESULTS
Clinical profile of EIAVWyo-infected pony 524
To accurately reflect the genetic diversity of an in vivo
infection, pony 524 was inoculated with the highly viru-
lent Wyoming strain of EIAV (EIAVWyo), which has been
maintained by serial in vivo passage (Oaks et al., 1998).
his inoculum represents a heterogeneous population of
irus, similar to a natural infection. After inoculation, pony
24 experienced a clinical disease course characterized
y recurring fever cycles interspersed with afebrile peri-
ds ranging from days to months (Fig. 1A). The initial
cute episode included a biphasic febrile response and
hrombocytopenia from 10 to 22 days postinfection (DPI).
he pony was then afebrile until 39 DPI. Thereafter, pony
24 underwent a period of seven recurrent fever epi-
odes, which ranged from 2 to 6 days in length. The last
ever episode ended after Day 135, and pony 524 re-
ained afebrile except for two late fever episodes at
ays 565 and 799. Febrile episodes were defined as
ectal temperature greater than or equal to 101°F. Throm-
ocytopenia (platelet count less than 105 platelets/ml)
as also observed concurrent with the initial fever cy-
les. After the initial fever cycles subsided, pony 524
emained persistently thrombocytopenic throughout the
xperiment. Except for the fever and thrombocytopenia,
o other clinical signs were observed.
Semiquantitative RT-PCR was used to monitor virus
evels at various DPI (Fig. 1B). Consistent with previous
eports, high virus loads were found in the initial fever
eriod at 12 DPI but fell to a nearly undetectable level
uring the afebrile interval at 35 DPI. The highest virus
oad, 9.08 3 107 copies RNA/ml, was detected during the
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187EIAV Rev VARIATION IN VIVOrecurrent febrile period at 67 DPI. Levels of plasma viral
FIG. 1. Clinical and serological profile of pony 524. (A) Clinical profile of
EIAVWyo-infected pony 524, including platelet counts (gray line, primary
y-axis) and fever episodes (columns, secondary y-axis). Fever was defined
as rectal temperature greater than or equal to 101°F. (B) Virus load, as
measured by copies of RNA/ml serum, was determined by semiquantita-
tive RT-PCR for the days indicated by open circles. (C) Virus neutralizing
(VN) antibody titer of pony 524 to EIAVWSU-5. VN titers were determined as
escribed under Materials and Methods from serum samples obtained at
, 11, 35, 67, 89, 118, 201, 289, 498, 754, and 800 DPI.RNA decreased somewhat in the subclinical period and
were barely detectable at 754 DPI. However, virus re-bounded to 1.38 3 105 copies/ml at 800 DPI. Virus neu-
tralization assays to EIAVWSU-5, a cell-culture-derived
strain of EIAVWyo (O’Rourke et al., 1988), indicated that
broadly reacting neutralizing antibodies appeared after
the chronic fever cycles subsided (201 DPI) (Fig. 1C).
Pony 524 maintained elevated neutralizing antibody to
EIAVWSU-5 throughout the remainder of the experiment.
Quasispecies distribution of the inoculum and
statistical analysis of sampling procedure
A potential problem with current methods used to
characterize viral variants is the possible selection of a
subpopulation of variants that may not be reflective of the
population present in vivo. To confirm that the selected
primer pairs did not bias the distribution of observed
variants, statistical analyses were performed on the dis-
tribution of variants obtained by RT-PCR amplification of
the inoculum. Sequences were amplified using four dif-
ferent sets of primer pairs (Table 1), designed from con-
served regions flanking exon 2 of rev. Chi-square analy-
es indicated that the frequency of observed variants in
he inoculum was not systematically biased during PCR
mplification (not shown). Thus, the observed quasispe-
ies population is likely to be reflective of variant fre-
uencies in vivo.
A total of 61 individual clones, at least 10 from each
rimer pair, were sequenced from the EIAVWyo inoculum.
At the nucleotide level, 39 different genotypes were de-
tected and translated into both the Rev and the gp45
ORFs. A total of 25 different Rev amino acid variants,
designated R1 through R25, were observed in the Rev
ORF (Fig. 2). Five genotypes were observed at a fre-
quency greater than 1, and two clones, R1 and R2, ac-
counted for 30 and 25% of the sample population, re-
spectively. Translation in the gp45 ORF identified 30
different variants, designated E1–E30 (Fig. 2). The in-
creased number of variants in gp45 as compared to Rev
was primarily the result of an R to Q change at position
TABLE 1
Primer Pairs Used for Amplification of EIAV Rev Sequences
Primer
pair
Primer
namea Primer sequence (59–39)
1 EM 7066 CAATTTGGCACAATCCATGA
EM 7674C GCGAGAGTTCCTTCTTGGGC
2 EM 7066 CAATTTGGCACAATCCATGA
EM 7680CRI GGAATTCCGAGAGTTCCTTCTTGG
3 EM 7160 GGATTGGGAGCTTCCATTAT
EM 7674C GCGAGAGTTCCTTCTTGGGC
4 EM 7160 GGATTGGGAGCTTCCATTAT
EM 7680CR1 GGAATTCCGAGAGTTCCTTCTTGG
a C indicates the primer is on the complementary (antisense) strand,
and R1 indicates the presence of an EcoRI restriction site (underlined)
at the 39 end.
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188 BELSHAN ET AL.129 of gp45, which was a silent change in the Rev ORF.
Eight gp45 genotypes were observed more than once,
and the predominant variant, E1, accounted for 16% (10/
61) of the population.
Genetic changes in rev/gp45
To analyze variation throughout infection, RNA was
solated from the inoculum and from sera samples col-
ected at various stages of clinical disease, including:
cute febrile (12 DPI), first afebrile interval (35 DPI),
ecurrent febrile (67, 89, and 118 DPI), afebrile (201, 289,
85, and 437 DPI), and late febrile (754 and 800 DPI)
FIG. 2. Frequency and distribution of Rev and gp45 sequences in EIA
equenced and translated into the Rev and gp45 open reading frames.
or each reading frame. The sequence of the dominant variant (R1 or E
hown. ( z ) Indicates an identical aa to R1 or EI at that position and (2eriods. The rev exon 2/gp45 overlapping region of EIAV
was amplified using primer pairs 2 and (Table 1), and 22to 26 individual clones were sequenced at each time
point. Sequences from each time point represent data
from two independent RT-PCR reactions. Novel variants
were detected at each time point, and the greatest num-
ber of new variants was observed at 67, 89, 118, and 201
DPI, corresponding to the recurrent fever period and the
first sample of the afebrile period (Table 2).
The amplified region contains overlapping reading
frames for two viral proteins, and we used a variety of
genetic analyses to evaluate the potential significance of
genetic changes in each reading frame. Consistent with
observations of other retroviruses (Kim et al., 1996), we
culum. rev/gp45 was amplified from the inoculum and 61 clones were
riant identity (V) and the number of clones of each variant (N) are given
en, and the changes in amino acid sequence in all other variants are
ates a 21 frameshift mutation.VWyo ino
The vaobserved a high ratio of transition (Ts) to transversion
(Tv) at each time point. There was also a high ratio of
NR
189EIAV Rev VARIATION IN VIVOnonsynonymous (N) to synonymous (S) mutations in both
ORFs of the overlapping region (Table 2). At most time
points, the N/S ratio was similar for both reading frames,
although disproportionate values were sometimes ob-
served. At Day 437, for example, there were 15 nt
changes in all the sequences: in the Rev ORF, there was
one change in the first codon position, seven in the
second codon position, and seven in the third codon
position. One of the changes in the third codon occurred
concurrent with a second codon change, resulting in six
synonymous changes in Rev and nine nonsynonymous
changes, or an N/S of 1.5. In the gp45 reading frame, the
codon positions change with respect to Rev, resulting in
seven changes in the first codon position, seven in the
second codon position, and one in the third codon posi-
tion, resulting in an N/S ratio of 14/1 for Env. The overall
N/S ratio was greater than 1 for both Rev (1.54) and gp45
(2.15), suggesting that variation in this region was the
result of selective pressure. Application of the Tajima test
(Tajima, 1989), which is a widely used procedure to
determine whether nucleotide variation within a region
was the result of either selective pressure or neutral
mutations, confirmed that this region was indeed under
selective pressure. Together, the results of the genetic
analyses indicated a continuing evolution in Rev and
gp45 throughout infection, with changes resulting from
selective pressure in both reading frames.
Rev variation throughout clinical disease
The genetic analyses suggested that variation in Rev
T
Genetic Analysis of Va
Inoc. 12 35 67 8
Total clonesa 61 24 23 23 24
Tb Variantsc 39 13 12 14 20
New variantsd 39 10 7 9 17
evb Variantsc 25 7 11 13 18
New variantsd 25 6 7 9 14
N/Se 1.0 0.9 7 2.2 2
gp45b Variantsc 30 7 10 14 16
New variantsd 30 5 4 11 12
N/Se 2.3 1.2 2.2 4.0 1
a Number of clones sequenced at each time point.
b Analysis of variation in nucleotide sequence (NT) or amino acid se
c Number of distinct genotypes present at each time point.
d Number of new genotypes not previously observed.
e Ratio of nonsynonymous to synonymous mutations in that ORF.was the result of selection rather than neutral mutations.
We previously showed that genetic variation could alterRev activity, and we focused our subsequent analyses on
variation in the Rev ORF. Rev amino acid sequences
were examined from the inoculum (Fig. 2) and from each
of the 11 time points following infection (Fig. 3). As
described above, the inoculum was predominated by two
Rev amino acid variants, R1 and R2, which accounted for
30 and 25% of the sample population, respectively. The
consensus sequence for the inoculum was identical to
the sequence of R1. The genetic variation observed was
not distributed uniformly across Rev, and there were two
main regions of variability. Few changes were observed
in the nuclear export sequence, which was previously
mapped to aa 2–25 (Fridell et al., 1993; Mancuso et al.,
1994). However, amino acid position 25, located at the
C-terminus of the nuclear export signal, was highly vari-
able, with either a consensus serine or a leucine muta-
tion at that position (S25L). At positions 104–108, there
was a GDYQQ consensus sequence, with DGYQR ap-
pearing in a small number of variants. The C-terminal
region of EIAV rev is highly basic, and a putative nuclear
localization signal was previously mapped to this region
(Harris et al., 1998). There were only two changes in the
C-terminal region, and both changes retained or in-
creased the basic character of this region. Changes in
the Rev quasispecies were examined at varying stages
of clinical EIAV.
Acute stage. The consensus sequence of R1 was used
as the standard by which the subsequent sera samples
were compared. During the early period after infection,
there were no changes in the consensus sequence
in rev and gp45 ORFs
ys postinoculation (DPI)
Total118 201 289 385 437 754 800
24 25 22 26 23 24 23 322
15 20 9 15 12 11 13
12 15 4 10 6 7 9 145
11 16 8 12 6 7 8
8 12 3 7 1 5 4 101
1.9 2.4 1.8 2.1 1.5 2.0 1.2
11 15 8 10 12 8 11
7 10 2 4 6 5 9 105
1.9 4.2 3.2 2.1 14 3.4 7.7
e in the Rev or gp45 open reading frame.ABLE 2
riation
Da
9
.6
.8
quenc(Figs. 3 and 4). The Rev quasispecies found in the initial
febrile episode at 12 DPI was genetically very homoge-
190 BELSHAN ET AL.FIG. 3. Alignment of Rev aa sequences obtained from sera of pony 524 at 12, 35, 67, 89, 118, 201, 289, 385, 437, 754, and 800 DPI. The variant identity
(V) and number of clones of each variant (N) are given for each time point, as well as the total number of clones sequenced (below the N column).
Dominant variants are highlighted in bold. Sequences are compared to R1, which is listed at the top of each time point. For individual sequences,
( z ) indicates an identical aa to R1 at that position, (*) indicates a premature stop codon in the Rev ORF, and (1) indicates a 11 frameshift.
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192 BELSHAN ET AL.neous. The variant R1 remained the predominant variant,
accounting for 75% of the sample population. The re-
maining six variants had not been observed in the inoc-
ulum, and each differed from R1 by a single amino acid.
None of the variants contained changes at aa 25 or in the
GDYQQ region at 104–108. In the intervening afebrile
period at 35 DPI, the quasispecies resembled the inoc-
ulum. Both R1 and R2 variants were detected, and the
former was again the predominant variant. Also, we
observed two minor variants which had been present in
inoculum (R14, R17), and genetic variability was detected
at position 25 (S or L) and in the DGYQR motif at aa
104–108.
Recurrent febrile stage. The Rev quasispecies ob-
served in the recurrent febrile period (67, 89, and 118 DPI)
differed markedly from the previous populations, as re-
flected in the appearance of a new consensus sequence
at each time point sampled (Fig. 4). Notably, the variant
R1, which predominated both the inoculum and the sam-
ples from 12 and 35 DPI, was not detected in any of the
three samples taken during the recurrent febrile stage.
Variants and/or amino acid changes present as minor
populations in earlier time points grew in frequency to
predominate during the recurrent febrile period. For ex-
ample, variant R32 was only a minor variant at 35 DPI but
represented 43% of the population at 67 DPI. The con-
sensus sequence at 67 DPI was identical to that of R32
and had an alanine at aa 82 as well as the DGYQR motif
n region 104–108. At 89 DPI, R32 had decreased to 14%
f the population, and no variant accounted for more than
0% of the population at this time point. The consensus
equence at 89 DPI contained a GGYQR motif and was
epresented by the variant R12, a minor variant which
as also present in the inoculum and 67 DPI. R53 was
resent as a minor variant at 89 DPI and grew to pre-
ominate the quasispecies population at 118 DPI. R53
hared the consensus sequence at 118 DPI, which con-
ained an R97K substitution and a GGYQR motif in region
04–108. Throughout the recurrent febrile period, minor
ariants were observed which contained amino acid
ubstitutions in the NES, although none contained the
2-like S25L. In summary, the recurrent febrile period
as characterized by continual changes in the consen-
FIG. 4. Consensus Rev aa sequences at each time point (DPI). The v
At two time points, 89 and 201 DPI, no variant was predominant and thus sequence, with minor variants growing to predomi-
ate at subsequent time points.
a
rAfebrile stage. The first serum sample analyzed after
he recurrent febrile episodes subsided was obtained at
01 DPI, and no variant accounted for more than 20% of
he population at this time point. Surprisingly, after going
ndetected throughout the recurrent febrile period, R1
as observed as a minor variant. Although R2, R17, and
32 were also present as minor variants, the consensus
equence at 201 DPI was unlike those previously ob-
erved. The sequence of R78 was identical to the con-
ensus sequence at 201 DPI and consisted of G80D,
97K, and Q108R. Position 25 was highly variable, with
everal variants containing a proline at that residue. At
a 104–108, both the GDYQQ and the DGYQR motifs
ere detected in addition to the consensus sequence
ontaining GDYQR. After 201 DPI, the frequency of R1
rew to predominate each time point analyzed during the
emainder of the afebrile period (289, 385, and 437 DPI),
nd the consensus sequence was identical to that of R1
t each of these time points. Overall, the identity of the
inor variants was not highly variable during the afebrile
tage, with R17, R32, and R33 observed in most of the
amples. In contrast to the continual appearance and
rowth of minor variants in the recurrent febrile stage,
he afebrile stage was relatively stable genetically and
redominated by R1.
Late febrile stage. Two late fever episodes occurred at
65 and 799 DPI. Analysis of rev variation included sam-
les collected at 754 and 800 DPI. R1 was observed as
minor variant at 754 DPI but was not detected at 800
PI. A new variant, R93, arose as the predominant vari-
nt and the consensus sequence at 754 and 800 DPI and
iffered from R1 by seven amino acids. Changes not
bserved in previous consensus sequences included
25P, V75A, and R112H. Other changes from R1 found in
he consensus sequence for 754 and 800 DPI were
80D, R97K, D105G, and Q108R, which had been part of
arlier consensus sequences.
In summary, the dynamics of the Rev quasispecies
volution were reflected by the changes in the consen-
us sequences during the course of disease (Fig. 4).
hese changes were exemplified by the disappearance
nd reappearance of R1, which was identical to the
onsensus sequence in the acute fever episode, the first
identity (V) and sequence, relative to R1, are given for each time point.
ensus sequence was represented by a minor variant, indicated by (*).febrile interval, and most of the afebrile period. The
eplacement of R1 by novel variants during both the
P , 0.
of EIA
193EIAV Rev VARIATION IN VIVOrecurrent and late febrile periods is reflected in changes
in the consensus sequence during those clinical stages
of EIAV infection. The finding that changes in rev con-
sensus sequences coincided with changes in the clinical
disease suggested differences in selective pressures at
sequential stages of disease. Surprisingly, these results
suggested that the host environment in the acute and
afebrile stages selected for similar Rev variants.
Biological activity of Rev quasispecies
Genetic analysis of rev variation suggested differ-
ences in selective pressure at different stages of clinical
disease. Therefore, it was important to determine the
biological activity of Rev variants observed in this study.
Because it was not practical to biologically test each
clone, Rev variants which were predominant or repre-
sentative of consensus sequences at any time point
were cloned into a eukaryotic expression vector contain-
ing rev exon 1. The Rev-mediated nuclear export activity
was determined in transient transfection assays as pre-
viously described (Belshan et al., 1998) and results were
normalized to R1 (Fig. 5A). R2, which contained the single
S25L change from R1, exhibited a level of activity similar
to that of R1. The variant R26 (R52G), which was detected
at 12, 118, and 754 DPI, was the only variant tested that
had significantly lower Rev activity (63%) than did R1.
Interestingly, all other variants assayed showed levels of
nuclear export activity that were significantly higher than
FIG. 5. Variation in Rev-mediated nuclear export activity correlates
variants from pony 524. Rev exon 2 variants were inserted into a euka
293 cells as described under Materials and Methods. CAT assays were
of activity compared to R1. Error bars denote the standard error of the
with P values represented by (*) P , 0.05, (**) P , 0.005, and (***)
(closed circles, solid line) quasispecies Rev activity at different stagesthat of R1 (P , 0.05). These included variants that were
identical to the consensus sequences during the recur-rent febrile and late febrile stages of disease (67, 89, 118,
754, and 800 DPI). The consensus sequences repre-
sented by the variants R12, R32, R53, and R93 all exhib-
ited approximately 165% activity relative to that of R1.
Other variants tested from the recurrent febrile stage,
R42, R45, and R51, also had Rev activity approximately
175%. Thus, the recurrent and late febrile periods were
predominated by Rev variants that had significantly
higher nuclear export activity than that of R1, which
predominated the acute and afebrile periods. Interest-
ingly, 201 DPI was characterized by the coexistence of
Rev variants with low activity (R1 and R2) and variants
which had relatively higher activity (R71 and R72). Simi-
larly, at 754 DPI, we observed a high frequency of R26
(63% activity) coexisting with the predominant R93 (153%
activity). It is possible that 201 and 754 DPI reflect qua-
sispecies transitions between different stages of clinical
disease.
Rev quasispecies activity correlates with clinical
stage of disease
Our analysis of selected Rev variants indicated that
changes in Rev phenotype were associated with
changes in clinical disease. As our data show, however,
rev variants existed as a quasispecies population, and
no one variant can define the phenotype of the quasi-
species. To determine whether the Rev quasispecies
activity was statistically correlated with different param-
mperature and clinical disease. (A) In vitro biological activity of Rev
xpression vector and transient transfection assays were performed in
lized to the activity of R1 and the results are presented as a percentage
Variants that differed significantly from the activity of R1 are indicated,
00005). (B) The predicted (open circles, dotted line) and experimental
V. The rectal temperature of pony 524 is indicated by solid bars.with te
ryotic e
norma
mean.eters of clinical disease, we attempted to approximate
the average phenotype for the Rev quasispecies at each
p
t
w
0
a
s
oint.
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194 BELSHAN ET AL.time point. The variants experimentally tested accounted
for at least 50% of all clones present at each time point.
Using the activity of each tested variant and its frequency
in the population, we calculated a weighted average to
derive an experimental quasispecies Rev activity at each
time point (Table 3). Using the phylogenetic relatedness
among the variants (not shown), the untested Rev vari-
ants were each assigned the same Rev activity as the
nearest tested variant, and a predicted quasispecies
activity was calculated. At each time point, the calculated
experimental and predicted quasispecies Rev activities
were nearly identical, differing at most by 8% (Table 2).
Comparison of quasispecies Rev activity with febrile re-
sponses of pony 524 indicated that the quasispecies Rev
activity was highest during the recurrent febrile and late
T
Experimental and Predic
Rev variant R1 R2 R4 R12 R17 R26 R32 R42
Rev activitya 100 96 222 169 131 63 176 158
Stage DPIb
Acute 12 18 f 0 0 0 0 1 0 0
35 6 2 0 0 2 0 2 0
Recurrent 67 0 0 0 1 2 0 10 1
89 0 0 0 2 1 0 4 3
118 0 0 0 2 0 2 0 0
Afebrile 201 3 4 0 0 1 0 1 0
289 9 4 0 0 2 0 1 0
385 11 4 0 0 0 0 1 0
437 11 4 0 0 1 0 4 0
Late febrile 754 4 0 0 0 0 6 0 0
800 0 0 0 0 0 0 0 0
a The nuclear export activity level of each variant tested (A i), relative
b The days postinfection from which the variants were isolated.
c The number of clones experimentally tested and the total number
d The experimental quasispecies Rev activity calculated for each tim
e The predicted quasispecies Rev activity calculated for each time p
f The number of times that variant was detected at that time point (v
T
Correlation between Quasispecies Rev Ac
Clinical parameter Virus titer
Platelet count
Temperature
Clinical disease stage Acute vs recurrent
Recurrent vs afebrilea P values calculated using Pearson correlation coefficients.
b P values using general linear models.febrile stages of EIA (Table 3, Fig. 5B). These findings
further suggested a correlation between Rev activity and
clinical stage of disease. Therefore, Pearson correlation
coefficients were calculated to test for correlation be-
tween the quasispecies Rev activity and various clinical
parameters, including virus titer, platelet counts, and
temperature of the horse (Table 4). No significance was
detected in comparisons of experimental or predicted
quasispecies Rev activity and virus titer (P . 0.15) or
latelet count (P . 0.45). Analysis by Pearson correla-
ion coefficients found that the temperature of pony 524
as statistically correlated with the experimental (P 5
.007) and predicted (P 5 0.011) quasispecies Rev
ctivity. In addition, the results of the correlation analy-
es indicated that phenotypic variation in Rev was cor-
asispecies Rev Activity
R51 R53 R71 R72 R86 R93
Tested/
totalc EQRAd PQRAe
180 165 162 154 131 153
0 0 0 0 0 0 19/24 98 98
0 0 0 0 0 0 12/23 117 124
0 0 0 0 0 0 15/23 169 170
1 1 0 0 0 0 12/24 166 165
0 12 0 0 0 0 16/24 153 158
0 0 2 4 0 0 15/25 129 136
0 0 0 0 0 0 16/22 108 117
0 0 0 0 2 0 18/26 107 108
0 0 0 0 0 0 20/23 116 120
0 0 0 0 0 10 20/24 115 122
0 0 0 0 1 16 17/23 152 151
activity of R1, which is set at 100.
es at each time point.
t.
nd Clinical Parameters of EIAV Infection
xperimental quasispecies
Rev activity
Predicted quasispecies
Rev activity
0.157a 0.195a
0.453a 0.504a
0.007a 0.011a
0.013b 0.014b
0.010b 0.015bABLE 3
ted Qu
R45
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195EIAV Rev VARIATION IN VIVOrelated with changes in clinical stages of EIAV disease.
The experimental and predicted quasispecies Rev activ-
ities in the recurrent febrile stage were significantly
higher than the quasispecies Rev activities in the acute
period (P 5 0.013, P 5 0.014) and in the afebrile period
(P 5 0.010, P 5 0.015).
DISCUSSION
Antigenic variation in the surface envelope glycopro-
ein has long been recognized as an important mecha-
ism of immune evasion and lentivirus persistence. Re-
ent studies suggested that variation in other regions of
he viral genome, including the LTR and regulatory
enes, may also contribute to the clinical disease course
Carpenter et al., 1991; Maury et al., 1997; Leroux et al.,
997; Belshan et al., 1998; Hua et al., 1996). We and
others have observed a high degree of genetic variation
in the rev exon 2/gp45 region of EIAV (Belshan et al.,
1998; Leroux et al., 1997), and we previously demon-
strated that limited amino acid variation in EIAV Rev
alters biological activity (Belshan et al., 1998). It was
roposed that attenuation of the Rev phenotype may
llow EIAV to persist through downregulation of viral
ene expression and reduced replication, enabling the
irus to evade an effective immune response (Belshan et
l., 1998).
To delineate the significance of rev variation in vivo,
e examined both genetic and biological variation of Rev
n an experimentally infected pony. Genetic variation
bserved in rev during sequential stages of EIAV infec-
ion clearly demonstrated that rev variants exist as a
uasispecies population. Genetic analyses indicated
hat the Rev ORF evolved throughout infection and that
enetic variation was the result of selective pressure
ather than neutral mutations. The frequency at which
ew variants were detected was greatest during clinical
eriods, concomitant with higher levels of virus replica-
ion at these times. Genetic and phenotypic changes in
he Rev quasispecies coincided with changes in clinical
isease. Rev variants which were predominant during
he recurrent febrile period had significantly higher nu-
lear export activity than the variants predominant during
he acute or afebrile periods. Statistical analyses found
hat quasispecies Rev activity was correlated with tem-
erature of the infected pony but not with virus titer or
latelet count. Additionally, the quasispecies Rev activity
n the acute and afebrile stages was significantly lower
han the quasispecies Rev activity in the recurrent febrile
tage of disease. Together, these findings indicate that
ariants with high Rev activity have a selective advan-
age during the recurrent and late febrile stages of EIA
nfection. Therefore, variation in rev may be a contribut-
ng factor of EIAV disease progression.The dynamic evolution of Rev quasispecies during
equential stages of clinical EIA is exemplified bychanges in the frequency of R1. This variant, and the
closely related R2, clearly represented the predominant
genotype and phenotype in the inoculum and the early
time period following infection. During the subsequent
recurrent febrile period, R1 was replaced by a series of
closely related Rev variants with significantly higher bi-
ological activity. Surprisingly, R1 reappeared at 201 DPI
and predominated during the prolonged afebrile period.
Yet, R1 was replaced by the more biologically active R93
during the late febrile period. These genetic changes in
the Rev quasispecies were also reflected in the pheno-
typic changes in the quasispecies Rev activity, which
was highest during the recurrent febrile and late febrile
stages of disease. In total, these findings indicate that
there were changes in selective pressure at sequential
stages of clinical disease. Specifically, our results sug-
gest that changes in the host environment occurred
during the recurrent febrile period and, further, that these
changes selected for variants with significantly higher
Rev activity. At present, the selective pressures present
during the recurrent febrile period are not yet known.
Increased Rev activity did not correlate with virus titer, as
might be expected if the selective advantage was solely
dependent on the virus replication rate. It is possible that
a Rev-specific host immune response selects for differ-
ent Rev variants; however, immune evasion does not
explain the significant differences in the biological activ-
ity of selected Rev variants. Ongoing studies to identify
factors important in selection of Rev variants may in-
crease our understanding of mechanisms of EIAV patho-
genesis.
Viremia has long been associated with clinical epi-
sodes in EIAV-infected animals (Issel and Coggins,
1979). The abrogation of recurrent clinical episodes is
typically coincident with the maturation of the host im-
mune response and decline in virus replication (Ham-
mond et al., 1997). The appearance of broadly acting
neutralizing antibody in pony 524 at 201–289 DPI was
associated with the resolution of the recurrent febrile
period, although virus load remained high through most
of the afebrile period. Our model predicted that Rev
variant that predominated during febrile periods would
differ phenotypically from variants predominant during
afebrile periods. Indeed, the quasispecies Rev activity
was significantly higher in the recurrent febrile period
than in the afebrile period. However, our model did not
predict that quasispecies activity in the acute period
would differ significantly from that in the recurrent febrile
period, nor that the acute and afebrile periods would be
so genetically and phenotypically similar. The predomi-
nance of R1 during the acute period indicates that R1 is
a robust phenotype, capable of supporting high levels of
virus replication. In fact, the predominance of R1
throughout the afebrile period was associated with rel-
atively high levels of viremia and thrombocytopenia that
persisted until late in the afebrile stage of disease (754
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196 BELSHAN ET AL.DPI). If pony 524 had resolved to a clinically inapparent
state, in which virus load decreased to nearly undetect-
able levels and platelet counts returned to normal levels,
it is possible that the quasispecies Rev activity would
have been statistically correlated with virus load, or that
Rev variants less active than R1 would have been pre-
dominant during the afebrile period. In support of this,
the least-active variant, R26, comprised 25% of the ob-
served population at 754 DPI, where virus loads were
barely above the threshold of detection and platelet
counts were near normal levels.
The second exon of Rev is completely overlapped by a
portion of the cytoplasmic tail of the EIAV transmem-
brane protein gp45. Thus, nucleotide substitutions in this
region may alter Rev and/or gp45. Because of the con-
straints of maintaining functional proteins in both reading
frames, it might be expected that variation in this region
would be biologically significant. However, it is not im-
mediately obvious which reading frame determines se-
lective advantage. Previous studies of variation in rev/
gp41 of HIV-1 suggested that both genes evolved inde-
pendently and that the changes were the result of
selection in only one ORF (Martins et al., 1991). Our data
ould argue that EIAV rev/gp45 evolved as a result of
elective pressures in both reading frames. The overall
omplexity (number of aa variants at each time point) of
ev and gp45 was approximately the same throughout
nfection, and out of 146 nt variants, there was a similar
umber of total Rev and gp45 aa variants (101 and 105,
espectively). This suggests that changes in gp45 also
ontribute to the selective advantage of the observed
ev/gp45 variants. The cytoplasmic tail of TM plays im-
ortant and varied roles in lentivirus replication, and
tudies are ongoing to characterize the effect of gp45
ariation on EIAV replication. It is probable that variation
n both ORFs contribute to virus pathogenicity in vivo.
The underlying assumptions of the RT-PCR method are
hat all viral quasispecies are amplified with equal effi-
iency and that the resulting proportions are represen-
ative of the starting population. Although these assump-
ions have generally been accepted, some reports sug-
est that PCR amplification might result in selective
mplification of individual templates, especially in reac-
ions containing a heterogeneous population of tem-
lates (Polz and Cavanaugh, 1998; Suzuki and Giovan-
oni, 1999; Barnard et al., 1998; Suzuki et al., 1998).
revious studies suggested that interactions between
rimers and templates might alter the efficiency of tem-
late amplification and, thus, alter the sample population
Barnard et al., 1998; He et al., 1994; Suzuki and Giovan-
oni, 1999), or that primer pairs may systematically bias
CR amplification (Suzuki and Giovannoni, 1999; Polz
nd Cavanaugh, 1998; Barnard et al., 1998). However,
hese studies have generally involved two or three dif-
erent templates of known concentrations. The complex
ature of viral quasispecies in vivo can further compli-ate sequencing studies. Our statistical analyses of
rimer-pair bias in the inoculum indicated that the fre-
uency of observed variants was not systematically bi-
sed during PCR amplification, so the random samples
ere likely reflective of variant frequencies in vivo. The
isk of bias may have been reduced by designing prim-
rs to conserved target sequences and using primers
ith similar GC content and optimal annealing temper-
tures. Taken together, our results suggest that randomly
ampled viral populations obtained by RT-PCR can re-
lect in vivo populations. This offers confidence in the
haracterization of viral quasispecies present in vivo and
trengthens interpretations of studies examining the role
f virus variation in immune evasion and disease pro-
ression.
Most studies of EIAV persistence in vivo used a
loned, cell-culture-propagated virus as an inoculum and
ere limited to analysis of febrile periods. Inocula com-
rised of a homogenous population of virus have been
seful in identifying genetic changes that arise during an
n vivo infection. In this study, our intention was to better
eflect a naturally occurring infection in an experimen-
ally infected animal. Therefore, the inoculum used was
btained from a donor pony undergoing its first fever
pisode and represented a heterogeneous population of
irus rather than a single clonal population. Although this
ethod required a more extensive analysis, we believe it
rovided an accurate representation of the complex na-
ure of EIAV evolution throughout disease within a single
nfected pony. The heterogeneous nature of the inocu-
um, in combination with the extensive sampling and
enetic analysis at sequential time points, allowed us to
xamine the genetic variants that made up the rev qua-
ispecies and the biological phenotype of the Rev qua-
ispecies that were selected at variable stages of clinical
isease. It is clear that genetic and phenotypic changes
n the Rev quasispecies were associated with changes
n clinical stages of disease in this pony. While analysis
f additional EIAV-infected ponies is needed to fully elu-
idate the biological significance of Rev variation, the
indings presented here indicate that variation in virus
egulatory proteins can contribute to lentivirus persis-
ence.
MATERIALS AND METHODS
xperimental infection
The experimental infection of pony 524 was previously
eported (Oaks et al., 1998). The pony was infected in-
ravenously with 103 horse infectious doses of the highly
virulent Wyoming strain of EIAV (EIAVWyo). Physical exam-
inations, rectal temperatures, hemograms, and platelet
counts were performed daily during clinical episodes
and intermittently during chronic clinical disease or sub-
clinical infection. Sera and plasma were collected, pro-
cessed, and stored at 280°C until analyzed.
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197EIAV Rev VARIATION IN VIVOVirus neutralization assay
Assays were performed using equine dermal (ED)
cells maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 20% fetal bovine serum,
penicillin, and streptomycin as previously described
(Carpenter et al., 1987). ED cells were seeded 1 day prior
to infection at 105 cells/well in a six-well dish. Serum
from pony 524 was heat-inactivated at 60°C, to destroy
complement, and was serially diluted twofold in supple-
mented media. Five hundred focus-forming units of EIA-
VWSU-5, a cell culture-derived strain of EIAVWyo (O’Rourke et
al., 1988), in a 100-ml volume was incubated with 100 ml
of serially diluted pony 524 serum at 37°C for 1 h.
Duplicate wells of ED cells were inoculated with 100 ml
of virus–serum mixture in the presence of 8 mg/ml poly-
rene, and the media was changed the following day.
ells were incubated for an additional 72 h and fixed
ith 100% methanol, and immunocytochemistry was per-
ormed using convalescent anti-EIAV horse sera to de-
ect foci of virus-infected cells (Carpenter et al., 1987).
Results are expressed as the serum neutralization titer,
defined as the reciprocal of the highest serum dilution
that gave an 80% reduction in foci as compared with that
of preimmune and negative control serum.
Amplification and sequence analysis of viral variants
EIAVWyo inoculum was obtained as a serum sample
collected from an experimentally infected foal experienc-
ing its initial fever episode at 7 days postinfection (DPI).
To obtain viral RNA, 100 ml of EIAVWyo inoculum or pony
524 serum was pelleted by centrifugation at 93,000g for
1 h at 4°C. Viral RNA was isolated from these pellets by
guanidine thiocyanate lysis and acid phenol–chloroform
extraction using a commercially available kit (Ambion,
Austin, TX) and resuspended in 24 ml RNase-free glass-
distilled water containing 0.1 mM EDTA. RNA samples
were DNase I treated using the methods of Huang et al.
(1996). Briefly, two units of DNase I (Ambion) were added
to 3 ml of viral RNA, 20 mM MgCl2, 1 mM of each dNTP,
13 PCR buffer II (Perkin–Elmer, Branchburg, NJ), 20 units
of RNase inhibitor, and 2.5 mM of random hexamers in a
total volume of 20 ml. The reaction was incubated at
37°C for 30 min and heated to 75°C for 5 min to inacti-
vate the DNase I. After cooling to 4°C, 50 units of Molo-
ney murine leukemia virus reverse transcriptase were
added. Reactions were incubated at 42°C for 45 min,
heated to 99°C for 5 min to inactivate the reverse tran-
scriptase, and then cooled to 5°C for 5 min. The reaction
was brought up to 100 ml in 13 PCR buffer II with 2 mM
gCl2, 0.2 mM of each dNTP, 2.5 units Taq polymerase
(Perkin–Elmer), and 1 mM of each primer.
Primers were designed based on conserved regions
flanking the second exon of rev (Table 1). PCR amplifi-
cation conditions consisted of 37 cycles of denaturation
at 94°C for 2 min, annealing at 50°C for 1 min, and
t
9extension at 72°C for 1 min. The initial and final cycles
contained a prolonged extension at 72°C for 5 min. A
2-ml aliquot of PCR product was TA-cloned into pGEM-T
vectors as recommended by the manufacturer (Promega,
Madison, WI) and transformed into Escherichia coli DH-
a. Positive clones were identified by colony blot hybrid-
ization using a subgenomic fragment of rev labeled with
32P]dTTP by random-primed labeling (Roche Molecular
Biochemicals, Indianapolis, IN). Plasmids were isolated
from positive clones using a commercially available kit,
Wizard Plus Miniprep (Promega), and the rev inserts
ere sequenced bidirectionally with vector primers
lanking the insert. All sequencing was performed by the
owa State University DNA Synthesis and Sequencing
acility using an automated DNA sequencer. Sequences
ere aligned by MacVector and AssemblyLIGN software
Oxford Molecular, Beaverton, OR). To estimate the RT-
CR error rate, viral mRNA was isolated from a clonal
ell line stably transfected with an EIAV proviral DNA
lone, reverse transcribed and amplified with Taq poly-
erase. The amplicons were cloned and 17 individual
lones were sequenced. The error rate of the RT-PCR
mplification procedure was determined to be 0.025%, or
hree substitutions per 11,991 base pairs sequenced.
onstruction of Rev expression vectors
rev variants were subcloned into pERevWT, a Rev
xpression vector previously described as pcH21 (Bel-
han et al., 1998). This plasmid contains Rev cDNA in the
CR3 background (Invitrogen, Carlsbad, CA). pERevWT
as digested with the restriction endonuclease ApaI to
emove rev exon 2. The digested plasmid was gel-puri-
fied, dephosphorylated, and ligated with the exon 2 se-
quence variants. Two methods, based on the direction of
the inserts in pGEM-T, were employed to move variant
exon 2 sequences into the pERevWT background. In-
serts in the “forward” direction were digested with ApaI,
gel-purified, and ligated into the digested pcRevWT
background. Inserts in the “reverse” orientation were
PCR-amplified with the EM7160 primer and a 39 EIAV
primer containing an ApaI site (underlined): 59-CTGGGC-
CCTCATAAATGTTTCCTCCTTCGC. The PCR products
were purified, digested with ApaI, and ligated into the
pcRevWT background. All clones were verified for direc-
tionality by restriction mapping and confirmed by se-
quencing.
Statistical analyses
A two-dimensional chi-square test was used to test
the null hypothesis that the frequency distribution of
observed variants and the choice of primer pairs was
independent. The chi-square statistic was calculated,
and the P value was determined for each contingency
able. The statistical threshold used in this study was
5% confidence. Subset pairwise analyses were also
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198 BELSHAN ET AL.performed on the data, and the results were interpreted
with Bonferroni’s correction (Miller, 1981). For the Monte
Carlo simulation (Rubinstein, 1981) comparing the four
primer pairs, the chi-square distance was calculated
between the four sets of simulated data. The data were
simulated 10,000 times, and experimentally observed
chi-square distances were compared with the 10,000
simulated distances to find the percentile ranking, which
correlates to the P value. For the pairwise analyses of
rimer pairs, 10 variants were randomly created for each
et of the two simulated primer pairs. The remainder of
he simulation was the same as just described, except
he Kullback distance (Bishop et al., 1975) was calculated
ather than chi-square distance.
The transition to transversion ratio and the nonsynony-
ous-to-synonymous mutation ratio were calculated us-
ng the program SITES, version 1.1 (Hey and Wakeley,
997). The Tajima test (Tajima, 1989), which determines
hether nucleotide variation within a region was the
esult of selective pressure or neutral mutations, was
lso performed using SITES.
The experimental quasispecies Rev activity (QRA) for
ach time point was calculated as the average Rev
ctivity of tested variants, weighted by frequency of the
ested variants, using the following equation:
QRA 5 F 1¥ i51n v iG Oi51
n
v i Ai
where n is the number of different variants tested, v i is
the number of times variant i was detected at that time
point, and A i is the Rev activity level for variant i. A
phylogenetic tree was constructed, and untested vari-
ants were assigned the same activity as the nearest
tested variant in the tree. These values were used to
estimate the predicted quasispecies Rev activity in a
manner similar to the calculation of the experimentally
Rev quasispecies activity. The statistical package SAS,
version 6.03 (SAS Institute, 1988), was used to examine
possible correlation between the experimental and pre-
dicted quasispecies Rev activity and different parame-
ters of clinical disease. Pearson correlation was used to
test virus titer, platelet counts, and temperature of the
infected pony. A quadratic model was used to fit the
relationship between quasispecies Rev activity and tem-
perature, and analysis of the studentized residuals was
used to test the quadratic model. Comparison of quasi-
species Rev activity between different stages of disease
was done using a general linear models procedure,
adjusted for multiple comparisons by Tukey–Kramer cor-
rection.
Quantification of virus loadRNA quantification standards were synthesized by in
vitro transcription from a linearized plasmid containing a450-base pair fragment of EIAV gag (pEIAp26.1). The RNA
was purified by extraction with Trizol reagent, treated
with 6 U of DNase I (Ambion) for 45 min at 37°C to
remove plasmid DNA, and then extracted again with
Trizol reagent. Final RNA preparation was quantified by
spectrophotometry, aliquoted, and stored at 280°C. The
bsence of contaminating plasmid DNA was verified by
CR without reverse transcription.
To create standards, known copy numbers of RNA
tandards were assayed in triplicate as described below;
hese included 2 3 107, 2 3 106, 2 3 105, 2 3 104, and
2 3 103 copies of RNA. Reaction products were visual-
ized in ethidium bromide-stained agarose gels, and their
densities quantified using a commercial digital imaging
system (IS1000; Alpha Innotech, San Leandro, CA). The
mean density for each copy number was plotted against
the log10 of the copy numbers to construct a standard
curve.
The one-tube, semiquantitative RT-PCR protocol was
modified from that described by Hamel et al. (1995). The
eaction buffer contained 50 mM KCl, 10 mM Tris (pH
.0), 0.1% Triton X-100, and 2.0 mM MgCl2, and each
reaction contained 0.4 mM deoxyribonucleotide mix
(Roche Molecular Biochemicals), 1 U of RNase inhibitor
Roche Molecular Biochemicals), 20 U of Moloney mu-
ine leukemia virus reverse transcriptase (SuperScript II;
ibco BRL, Rockville, MD), 1.5 U of Taq DNA polymerase
Gibco BRL), and 90 pmol of the forward primer (59-
CTACTTGGGTGAATACCAT) and 90 pmol of the reverse
rimer (59-TCTGCCTAAACTGATCAAAA) in a final volume
of 25 ml. These oligonucleotides prime both reverse
transcription as well as the subsequent PCR reaction,
and amplify a 322-base pair segment of the EIAV capsid
protein gene (p26) (nts 897–1199). Amplification was per-
formed as follows: 42°C for 40 min, DNase I inactivation
at 95°C for 3 min, and 40 cycles of 94°C for 30 s, 58°C
for 30 s, and 72°C for 30 s. Each RT-PCR run included
positive and negative controls. Complete removal of all
DNA from samples was confirmed by performing a du-
plicate reaction without reverse transcriptase. Following
amplification, 13 ml of the PCR reaction was analyzed by
electrophoresis through 2.0% agarose and visualized by
ethidium bromide staining and ultraviolet light. Serum
samples from each time point were assayed in duplicate,
and their mean density values were used to calculate
copy numbers of viral RNA from the standard curve.
RT-PCR reactions for standards and samples were per-
formed simultaneously using a reagent–master mix, and
were analyzed simultaneously in a single agarose gel.
CAT assays
293 cells were maintained in Dulbecco’s modified Ea-
gle’s medium supplemented with 10% fetal calf serum
and penicillin/streptomycin. Transient transfections and
CAT assays were performed using 293 cells as previ-
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199EIAV Rev VARIATION IN VIVOously described (Belshan et al., 1998). Briefly, 1 mg of
either pcDNA3 or Rev variant plasmid was transfected by
calcium phosphate coprecipitation with 0.2 mg of pERRE-
All reporter plasmid, 0.2 mg of pCH110 (Amersham Phar-
macia Biotech, Piscataway, NJ), and 0.6 mg of pUC19.
pERRE-All, a derivative of pDM138 containing EIAV nts
5280–7534, was described previously (Belshan et al.,
998). Each experiment also included a sham group,
hich contained no reporter plasmid, but an additional
.2 mg of pUC19. Two days posttransfection, cells were
harvested, resuspended in 0.3 ml 0.25 M Tris (pH 7.5),
lysed by freeze/thawing, and assayed for b-galactosi-
dase activity, to normalize CAT assays for transfection
efficiency. Normalized lysates were assayed for CAT
activity in a 0.1 ml volume with 3 ml [14C]chloramphenicol
and 1 mM acetyl CoA. Acetylated products were sepa-
rated by thin-layer chromatography and the percentage
of acetylation was determined by quantification by phos-
phorimager. Experiments were performed in triplicate
and results summarize a minimum of nine independent
transfections. Statistical significance was determined by
analysis of variance.
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